A Pediatric Hematologist and Oncologist specializes in diagnosing and treating blood disorders, childhood cancers, and immune-related conditions in infants, children, and adolescents. These include leukemia, lymphoma, solid tumors, anemia, thalassemia, bleeding disorders, bone marrow failure syndromes, and immune deficiencies. Care extends beyond treatment to include accurate diagnosis, chemotherapy, immunotherapy, bone marrow transplantation, supportive care, and long-term follow-up. The goal is to provide personalized, evidence-based treatment while supporting the child's overall health, development, and quality of life.

Childhood leukemia often presents with symptoms that may resemble common illnesses, making early evaluation important. Persistent fever, unusual tiredness, frequent infections, easy bruising or bleeding, pale skin, bone or joint pain, swollen lymph nodes, and unexplained weight loss are common warning signs. Some children may also develop enlarged liver or spleen. While these symptoms do not always indicate leukemia, persistent or unexplained symptoms require prompt assessment by a Pediatric Hematologist for accurate diagnosis and timely treatment.

Children should be evaluated by a Pediatric Hematologist if they have persistent anemia, recurrent infections, prolonged fever, unexplained bruising, excessive bleeding, enlarged lymph nodes, abnormal blood counts, or a family history of inherited blood disorders. Children diagnosed with conditions such as thalassemia, sickle cell disease, immune deficiencies, or suspected blood cancers also require specialized care. Early consultation helps establish an accurate diagnosis, initiate appropriate treatment, and prevent complications through comprehensive long-term management.

Pediatric Bone Marrow Transplantation, also known as Hematopoietic Stem Cell Transplantation, is an advanced treatment used for selected childhood cancers, bone marrow failure syndromes, immune deficiencies, and certain inherited blood disorders. The procedure replaces damaged or diseased bone marrow with healthy stem cells from the patient or a suitable donor. It is performed after careful evaluation and requires specialized multidisciplinary care before, during, and after transplantation to improve outcomes and reduce treatment-related complications.

Pediatric Oncologists manage a wide range of childhood cancers, including leukemia, lymphoma, brain tumors, neuroblastoma, Wilms tumor, bone cancers, liver tumors, and other solid tumors. Each condition requires individualized treatment based on the child's age, disease type, stage, and overall health. Modern pediatric oncology combines chemotherapy, surgery, radiation therapy, targeted therapy, immunotherapy, and supportive care to achieve the best possible outcomes while minimizing long-term treatment effects.

CAR T-cell therapy is an advanced form of immunotherapy that uses genetically modified T-cells to identify and destroy cancer cells. It is primarily considered for selected children with relapsed or treatment-resistant blood cancers, particularly certain types of leukemia and lymphoma. Eligibility depends on several clinical factors and requires detailed evaluation by a Pediatric Hematology-Oncology team. CAR T-cell therapy has significantly expanded treatment options for children who have not responded adequately to conventional therapies.

Diagnosing childhood blood disorders involves a detailed medical history, physical examination, and specialized laboratory investigations. Blood tests such as complete blood count, peripheral smear, coagulation profile, and biochemical studies are commonly performed. Depending on the suspected condition, bone marrow aspiration, bone marrow biopsy, genetic testing, immunophenotyping, or molecular diagnostics may also be required. These investigations help identify the exact disorder and guide individualized treatment planning for the child.

Treatment depends on the specific diagnosis and severity of the condition. Pediatric Hematology and Oncology services may include chemotherapy, immunotherapy, targeted therapy, blood transfusions, clotting factor replacement, iron chelation therapy, antibiotics, supportive care, stem cell transplantation, and long-term follow-up. Every treatment plan is individualized based on evidence-based clinical protocols, ensuring children receive the safest and most effective care while minimizing treatment-related complications and supporting healthy growth and development.

Supportive care plays a vital role throughout childhood cancer treatment by helping prevent infections, manage treatment-related side effects, maintain nutrition, relieve pain, and support emotional well-being. Children may receive blood product support, medications to reduce nausea, nutritional guidance, infection prevention strategies, psychological counseling, and rehabilitation services. A multidisciplinary approach involving pediatric specialists, nurses, nutritionists, psychologists, and rehabilitation experts helps improve treatment tolerance and overall quality of life.

Many children diagnosed with leukemia or lymphoma achieve long-term remission and lead healthy, productive lives following appropriate treatment. Advances in pediatric oncology, standardized treatment protocols, improved supportive care, targeted therapies, and bone marrow transplantation have significantly improved survival rates. The outcome depends on factors such as the specific cancer type, disease stage, genetic characteristics, and response to treatment. Regular follow-up remains essential to monitor recovery and long-term health.

Children who have completed cancer treatment require regular follow-up to monitor recovery, detect recurrence early, manage treatment-related effects, and support healthy physical and emotional development. Follow-up evaluations may include clinical examinations, laboratory investigations, imaging studies, growth assessments, and organ function monitoring. Survivorship care also focuses on education, preventive healthcare, vaccinations, nutrition, and psychosocial support, helping children transition successfully into adolescence and adulthood with the best possible quality of life.

Dr. Janani Arul is a Consultant Pediatric Hematologist and Oncologist with specialized fellowship training in childhood blood disorders, pediatric cancers, and bone marrow transplantation. She combines evidence-based clinical practice with compassionate, family-centered care to provide individualized treatment for leukemia, lymphoma, solid tumors, benign hematological disorders, immune deficiencies, and other complex conditions. Working collaboratively with multidisciplinary specialists, she is committed to delivering comprehensive, advanced, and personalized care that prioritizes the best possible outcomes for every child.